Change in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life Conditions

CompletedOBSERVATIONAL
Enrollment

246

Participants

Timeline

Start Date

November 15, 2019

Primary Completion Date

December 19, 2023

Study Completion Date

December 19, 2023

Conditions
Asthma
Trial Locations (50)

Unknown

Research Site, Aschaffenburg

Research Site, Augsburg

Research Site, Bamberg

Research Site, Beelitz

Research Site, Berlin

Research Site, Biberach

Research Site, Bonn

Research Site, Bremen

Research Site, Cottbus

Research Site, Darmstadt

Research Site, Dresden

Research Site, Düsseldorf

Research Site, Flensburg

Research Site, Frankfurt

Research Site, Fürstenwalde

Research Site, Gelsenkirchen

Research Site, Gerlingen

Research Site, Gotingen

Research Site, Halberstadt

Research Site, Halle

Research Site, Hamburg

Research Site, Hanover

Research Site, Heidelberg

Research Site, Hemer

Research Site, Hettstedt

Research Site, Ibbenbueren

Research Site, Immenhausen

Research Site, Konstanz

Research Site, Leipzig

Research Site, Magdeburg

Research Site, Marburg

Research Site, Markkleeberg

Research Site, München

Research Site, Neu-Isenburg

Research Site, Peine

Research Site, Radebeul

Research Site, Regensburg

Research Site, Reinfeld

Research Site, Rheine

Research Site, Rostock

Research Site, Roth

Research Site, Saalfeld

Research Site, Schleswig

Research Site, Teuchern

Research Site, Treuenbrietzen

Research Site, Waren

Research Site, Warendorf

Research Site, Wedel

Research Site, Wiesbaden

Research Site, Witten

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY